Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pentacyclic Triterpenes | 4 | 2024 | 36 | 1.270 |
Why?
|
| Triterpenes | 3 | 2019 | 78 | 1.260 |
Why?
|
| Nanoparticles | 7 | 2024 | 1966 | 0.840 |
Why?
|
| Deoxycytidine | 2 | 2024 | 886 | 0.780 |
Why?
|
| Drug Compounding | 2 | 2020 | 236 | 0.640 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 3943 | 0.540 |
Why?
|
| Nanostructures | 1 | 2019 | 549 | 0.460 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 686 | 0.460 |
Why?
|
| Colorectal Neoplasms | 3 | 2024 | 6962 | 0.440 |
Why?
|
| Metabolome | 1 | 2021 | 1009 | 0.440 |
Why?
|
| Cell Line, Tumor | 11 | 2024 | 17082 | 0.330 |
Why?
|
| Doxorubicin | 3 | 2021 | 2228 | 0.330 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1319 | 0.320 |
Why?
|
| HT29 Cells | 3 | 2019 | 187 | 0.320 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 5453 | 0.310 |
Why?
|
| Autophagy | 1 | 2016 | 1349 | 0.290 |
Why?
|
| Antineoplastic Agents | 5 | 2023 | 13639 | 0.290 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 595 | 0.290 |
Why?
|
| Drug Carriers | 2 | 2020 | 702 | 0.260 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 5194 | 0.250 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2024 | 2477 | 0.230 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2533 | 0.220 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2023 | 148 | 0.200 |
Why?
|
| Aptamers, Nucleotide | 1 | 2023 | 163 | 0.190 |
Why?
|
| CCN Intercellular Signaling Proteins | 1 | 2021 | 24 | 0.190 |
Why?
|
| Catechin | 1 | 2021 | 69 | 0.180 |
Why?
|
| Polymers | 3 | 2022 | 1624 | 0.160 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 8716 | 0.160 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2019 | 157 | 0.160 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 293 | 0.150 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 966 | 0.140 |
Why?
|
| Apoptosis | 5 | 2021 | 9507 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 4049 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1765 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 5696 | 0.130 |
Why?
|
| Mice | 6 | 2024 | 81863 | 0.120 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 1762 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2024 | 2495 | 0.120 |
Why?
|
| Vacuoles | 1 | 2016 | 224 | 0.120 |
Why?
|
| Rats | 4 | 2024 | 23718 | 0.120 |
Why?
|
| Particle Size | 1 | 2019 | 1634 | 0.120 |
Why?
|
| Mutation | 2 | 2024 | 30220 | 0.110 |
Why?
|
| Brain | 1 | 2021 | 27156 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1490 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2019 | 1900 | 0.110 |
Why?
|
| Animals | 10 | 2024 | 168887 | 0.110 |
Why?
|
| Tissue Distribution | 3 | 2023 | 2275 | 0.110 |
Why?
|
| Caspase 8 | 1 | 2013 | 198 | 0.100 |
Why?
|
| Metabolomics | 1 | 2021 | 1675 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 2329 | 0.090 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10438 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2021 | 2977 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4270 | 0.090 |
Why?
|
| Spheroids, Cellular | 2 | 2021 | 328 | 0.080 |
Why?
|
| Receptor, erbB-2 | 1 | 2019 | 2597 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 5334 | 0.080 |
Why?
|
| Cadherins | 1 | 2013 | 901 | 0.070 |
Why?
|
| Humans | 15 | 2024 | 766432 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 4356 | 0.070 |
Why?
|
| Polyethylene Glycols | 2 | 2023 | 1189 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 715 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 18322 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3601 | 0.050 |
Why?
|
| Apigenin | 1 | 2023 | 16 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2024 | 177 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3605 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 2947 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6508 | 0.050 |
Why?
|
| Terpenes | 1 | 2022 | 102 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2023 | 705 | 0.050 |
Why?
|
| Cell Survival | 2 | 2021 | 5741 | 0.050 |
Why?
|
| Cellulose | 1 | 2021 | 116 | 0.050 |
Why?
|
| Polycarboxylate Cement | 1 | 2020 | 17 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 2210 | 0.040 |
Why?
|
| Polyesters | 1 | 2021 | 373 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2020 | 338 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2022 | 1195 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2024 | 1807 | 0.030 |
Why?
|
| Endocytosis | 1 | 2019 | 952 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2020 | 2675 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 3610 | 0.030 |
Why?
|
| Cell Death | 1 | 2019 | 1676 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23611 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 6285 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 1674 | 0.020 |
Why?
|
| Neoplasms | 1 | 2020 | 22343 | 0.020 |
Why?
|
| Antibodies | 1 | 2019 | 2421 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2015 | 1881 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6217 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 3053 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2143 | 0.020 |
Why?
|
| Female | 4 | 2021 | 396354 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10740 | 0.010 |
Why?
|
| Cell Line | 1 | 2015 | 15563 | 0.010 |
Why?
|
| Male | 2 | 2020 | 363975 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 223127 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 223253 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 21157 | 0.010 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_